company? Let’s change
that.
Don't see your company?
Create a company profileBrand Protection ,Tracking & Engagement | Smart & Connected Packaging for Pharmaceutical | FMCG | Agro | and many more industry applications. Ennoventure Inc. was started in 2018 as an innovative venture with the aims of developing digital solutions , using advanced technologies like AI, Block chain and embedded solutions. Company has its headquarters in Massachusetts, USA and R&D center in Bengaluru, India. The company patented its breakthrough cryptographic technology to control parallel imports and counterfeit menace the same year. The state of the art technology can be used across multiple sectors on different product lines. *Enncrypto :-a simple easy-to-use solution using a versatile smartphone app to track and authenticate brands. incorporating patented future proof technology using AI, Cryptography and Block chain. *Ennteract :- embedded packaging takes the brands digital, allowing them to store a greater amount of information on package labelling, and displaying it in a multimedia formats. *VYU:-The customers would now need no scanners, optical readers or any such device to check the authenticity of a product. Any smartphone with data or Wi-Fi connectivity can be used to download the free Vyu app, and the customer is armed to check the veracity of the brands* they use.
Reliable Biopharmaceutical Corporation engages in the development and manufacture of active pharmaceutical and high purity ingredients.
AeroSafe Global provides the most reliable, simple and sustainable temperature sensitive supply chain solutions to the world’s leading biopharma companies. With proprietary packaging, logistics and operational services, AeroSafe builds customized solutions that ensure the safe delivery of temperature sensitive biopharmaceuticals. Our pay-per-use supply chain service, or “Cold Chain as a Service” (CSaaS) includes state-of-the-art packaging design, technology enabled logistics programs and cost reducing operational services. We reduce complexity, increase flexibility and create a sustainable, reliable solution for our valued customer.
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders
Biotechnology company inspired by globin chemistry and protein engineering focused on developing breakthrough antidotal therapies.
ERT is a global data and technology company.
NexusPharma is dedicated to the discovery of novel therapeutics.
The AMR Action Fund is a groundbreaking VC fund that enables breakthroughs in the development of antibiotics, anti-fungals, and other antimicrobials. We invest in companies developing innovative treatments for priority drug-resistant pathogens and advocate for market reforms and policy solutions to change how society values these lifesaving drugs
Microtek provides innovative product development by incorporating microelectronics, bioscience and pharmaceutical strategies.
ALT Bioscience engages in the discovery, development, and commercialization of diagnostic and biomedical technologies.
Hera Health Solutions is a pharmaceutical company specializing in the development and commercialization of long term treatments.
People Science is a direct-to-consumer scientific research company providing a scaled R&D platform for alternative medicines. The company is dedicated to the public good and is poised to revolutionize the alternative medicine landscape with its data-driven approach - empowering patients, consumers, providers, and scientists to collectively improve health outcomes. People Science is powered by our proprietary software technology called CHLOE (Consumer Health Learning and Organizing Ecosystem) that integrates clinical care with scientific research. The People Science research marketplace offers a new model of popular access, research participation, and education - networking patient communities with healthcare providers and scientists to provide scientifically proven optimal care in alternative medicines. Companies that make alternative medicines will hire People Science to study their medicines and to differentiate their products with the People Science Seal of Approval in the rapidly expanding alternative medicines market. Examples of alternative medicines include medical cannabis and cannabinoids, microbiome and probiotic interventions, functional medicine and nutritional supplements, and psychedelic medicines. People Science is a for-profit Public Benefit Corporation and we are seeking partners, clients, and investors who are aligned with our long-term vision and the value of this venture to society.
Focused on improving the health of student populations, TimelyMD offers universities and colleges a comprehensive, custom program centered around telehealth. TimelyMD’s campus-wide solution gives students one point of contact--anytime, anywhere--to get quality care and immediate treatment for medical or mental health concerns from board certified physicians and licensed counselors. TimelyMD’s telehealth programs optimize clinic resources and support clinic staff in delivering quality care to the right students at the right times. Visit timely.md for more information.
NOCD provides online therapy for obsessive-compulsive disorder (OCD), one of the most severe, prevalent, and misunderstood mental health conditions. Inside the NOCD telehealth platform, people with can-do live, face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions.
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
Prevacus is a drug development company working on the prevention and treatment of mild traumatic brain injury (mTBI) or concussion.
Discover how Excelra, a leader in biopharma data and analytics, uniquely blends scientific understanding with technological expertise. This dual mastery empowers innovative drug discovery and development, transforming research data into actionable insights for groundbreaking discovery. 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 Excelra’s interdisciplinary approach combines life science expertise with cutting-edge technology. This leads to confident, data-centric decisions, simplifying your data-driven drug discovery journey and accelerating your research. 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗖𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 At Excelra, collaboration is key. By co-creating solutions, we amplify your team's capabilities, blending scientific insight and technological acumen for more valuable discoveries and greater project control. 𝗙𝗿𝗼𝗺 𝗖𝗵𝗮𝗼𝘀 𝘁𝗼 𝗖𝗹𝗮𝗿𝗶𝘁𝘆: 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗗𝗮𝘁𝗮 We navigate the complexities of drug discovery, enhancing your success by structuring chaotic data into actionable insights, leveraging our scientific and technological prowess. 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗬𝗼𝘂𝗿 𝗚𝗼𝗮𝗹𝘀 Your goals of faster drug development and better patient outcomes are central to our mission. Committed to delivering insights and tangible progress, we ensure each data point contributes to your innovation journey, helping you 'Excelrate' towards success. 𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 Join us in redefining drug development. Our services span across the life science value chain, from molecule to market. At Excelra, each data point is a step towards a healthier future. Discover how partnering with us can 'Excelrate' your healthcare innovations.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA, Philadelphia, PA and Oxford, England, with manufacturing facilities in Ireland and Italy. We maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. Together, we are more than 3,100 experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to market. For more information, please see our website at www.jazzpharma.com and follow us on Twitter at @JazzPharma. For information on fraudulent schemes involving our company name and recruitment, please visit https://bit.ly/2J1EjMA. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.
The future of health is fast paced and complex, demanding a different approach. Established in 2001, our 1,300+ healthcare experts, combine their knowledge and expertise across our 4 core disciplines — Consulting; Medical; Marketing; and Policy, Access, Value, & Evidence. Working across the product and service lifecycle, from R&D to post launch, we engage our collective force to solve the complex healthcare challenges of today and tomorrow. We imagine a healthier world and build the connections to make it happen.
LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical industry. We secure and optimize your supply chain with our extensive qualified API partner network, global drug product development and manufacturing facilities, and regulatory and market intelligence services delivering customized solutions that get your products to market faster. Full-service, expert support that accelerates the new product pathway. Now that’s smart. • Established in 2005 • ISO 9001-2015 QMS certified company • CGMP systems in accordance with ICH Q7 • Main business segments: R&D / Biotech / CDMO / Specialty Pharma Companies, New Drug Delivery Technologies (NDA/505b2) – with heavy concentration on injectables, transdermal, nasal, inhalation, ophthalmic & sublingual drug deliveries Our products originate from our API manufacturing partner sites who are approved by the leading regulatory authorities, such as the US-FDA, EDQM, TGA, UK-MHRA, PMDA etc. LGM’s industry experience enables us to support our clients throughout the entire pathway of drug development, from discovery through commercial production. Based on the scale and scope of development projects with which we are involved, we are able to provide our customers with a seasoned perspective and valuable market insight. LGM Pharma has enhanced its position as a leading supplier of newly approved APIs, including full technical documentation and regulatory support. Our Clients: At LGM Pharma, our clients’ needs are our top priority, and we support our client base consisting of a diverse array of pharma companies, including: • Contract Research, Development & Manufacturing Organizations • Specialty Pharma and Novel Drug Delivery Systems • R&D & Biotech Companies • Generic Pharma Companies • Chemical Catalog Companies • OTC & Private Label Manufacturers • Academic & Government Laboratories • Pharmacy Compounding Industry